Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
U.S. Abecma collaboration with Bristol Myers Squibb’s (BMS)10.68M78.94%
ide-cel ex-U.S. service revenue from Bristol Myers Squibb’s (BMS)2.85M21.06%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States100.39M100.00%
